Cargando…

Risks of hormonally active pharmaceuticals to amphibians: a growing concern regarding progestagens

Most amphibians breed in water, including the terrestrial species, and may therefore be exposed to water-borne pharmaceuticals during critical phases of the reproductive cycle, i.e. sex differentiation and gamete maturation. The objectives of this paper were to (i) review available literature regard...

Descripción completa

Detalles Bibliográficos
Autores principales: Säfholm, Moa, Ribbenstedt, Anton, Fick, Jerker, Berg, Cecilia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213589/
https://www.ncbi.nlm.nih.gov/pubmed/25405966
http://dx.doi.org/10.1098/rstb.2013.0577
_version_ 1782341847088103424
author Säfholm, Moa
Ribbenstedt, Anton
Fick, Jerker
Berg, Cecilia
author_facet Säfholm, Moa
Ribbenstedt, Anton
Fick, Jerker
Berg, Cecilia
author_sort Säfholm, Moa
collection PubMed
description Most amphibians breed in water, including the terrestrial species, and may therefore be exposed to water-borne pharmaceuticals during critical phases of the reproductive cycle, i.e. sex differentiation and gamete maturation. The objectives of this paper were to (i) review available literature regarding adverse effects of hormonally active pharmaceuticals on amphibians, with special reference to environmentally relevant exposure levels and (ii) expand the knowledge on toxicity of progestagens in amphibians by determining effects of norethindrone (NET) and progesterone (P) exposure to 0, 1, 10 or 100 ng l(−1) (nominal) on oogenesis in the test species Xenopus tropicalis. Very little information was found on toxicity of environmentally relevant concentrations of pharmaceuticals on amphibians. Research has shown that environmental concentrations (1.8 ng l(−1)) of the pharmaceutical oestrogen ethinylestradiol (EE(2)) cause developmental reproductive toxicity involving impaired spermatogenesis in frogs. Recently, it was found that the progestagen levonorgestrel (LNG) inhibited oogenesis in frogs by interrupting the formation of vitellogenic oocytes at an environmentally relevant concentration (1.3 ng l(−1)). Results from the present study revealed that 1 ng NET l(−1) and 10 ng P l(−1) caused reduced proportions of vitellogenic oocytes and increased proportions of previtellogenic oocytes compared with the controls, thereby indicating inhibited vitellogenesis. Hence, the available literature shows that the oestrogen EE(2) and the progestagens LNG, NET and P impair reproductive functions in amphibians at environmentally relevant exposure concentrations. The progestagens are of particular concern given their prevalence, the range of compounds and that several of them (LNG, NET and P) share the same target (oogenesis) at environmental exposure concentrations, indicating a risk for adverse effects on fertility in exposed wild amphibians.
format Online
Article
Text
id pubmed-4213589
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher The Royal Society
record_format MEDLINE/PubMed
spelling pubmed-42135892014-11-19 Risks of hormonally active pharmaceuticals to amphibians: a growing concern regarding progestagens Säfholm, Moa Ribbenstedt, Anton Fick, Jerker Berg, Cecilia Philos Trans R Soc Lond B Biol Sci Articles Most amphibians breed in water, including the terrestrial species, and may therefore be exposed to water-borne pharmaceuticals during critical phases of the reproductive cycle, i.e. sex differentiation and gamete maturation. The objectives of this paper were to (i) review available literature regarding adverse effects of hormonally active pharmaceuticals on amphibians, with special reference to environmentally relevant exposure levels and (ii) expand the knowledge on toxicity of progestagens in amphibians by determining effects of norethindrone (NET) and progesterone (P) exposure to 0, 1, 10 or 100 ng l(−1) (nominal) on oogenesis in the test species Xenopus tropicalis. Very little information was found on toxicity of environmentally relevant concentrations of pharmaceuticals on amphibians. Research has shown that environmental concentrations (1.8 ng l(−1)) of the pharmaceutical oestrogen ethinylestradiol (EE(2)) cause developmental reproductive toxicity involving impaired spermatogenesis in frogs. Recently, it was found that the progestagen levonorgestrel (LNG) inhibited oogenesis in frogs by interrupting the formation of vitellogenic oocytes at an environmentally relevant concentration (1.3 ng l(−1)). Results from the present study revealed that 1 ng NET l(−1) and 10 ng P l(−1) caused reduced proportions of vitellogenic oocytes and increased proportions of previtellogenic oocytes compared with the controls, thereby indicating inhibited vitellogenesis. Hence, the available literature shows that the oestrogen EE(2) and the progestagens LNG, NET and P impair reproductive functions in amphibians at environmentally relevant exposure concentrations. The progestagens are of particular concern given their prevalence, the range of compounds and that several of them (LNG, NET and P) share the same target (oogenesis) at environmental exposure concentrations, indicating a risk for adverse effects on fertility in exposed wild amphibians. The Royal Society 2014-11-19 /pmc/articles/PMC4213589/ /pubmed/25405966 http://dx.doi.org/10.1098/rstb.2013.0577 Text en http://creativecommons.org/licenses/by/4.0/ © 2014 The Authors. Published by the Royal Society under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/, which permits unrestricted use, provided the original author and source are credited.
spellingShingle Articles
Säfholm, Moa
Ribbenstedt, Anton
Fick, Jerker
Berg, Cecilia
Risks of hormonally active pharmaceuticals to amphibians: a growing concern regarding progestagens
title Risks of hormonally active pharmaceuticals to amphibians: a growing concern regarding progestagens
title_full Risks of hormonally active pharmaceuticals to amphibians: a growing concern regarding progestagens
title_fullStr Risks of hormonally active pharmaceuticals to amphibians: a growing concern regarding progestagens
title_full_unstemmed Risks of hormonally active pharmaceuticals to amphibians: a growing concern regarding progestagens
title_short Risks of hormonally active pharmaceuticals to amphibians: a growing concern regarding progestagens
title_sort risks of hormonally active pharmaceuticals to amphibians: a growing concern regarding progestagens
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213589/
https://www.ncbi.nlm.nih.gov/pubmed/25405966
http://dx.doi.org/10.1098/rstb.2013.0577
work_keys_str_mv AT safholmmoa risksofhormonallyactivepharmaceuticalstoamphibiansagrowingconcernregardingprogestagens
AT ribbenstedtanton risksofhormonallyactivepharmaceuticalstoamphibiansagrowingconcernregardingprogestagens
AT fickjerker risksofhormonallyactivepharmaceuticalstoamphibiansagrowingconcernregardingprogestagens
AT bergcecilia risksofhormonallyactivepharmaceuticalstoamphibiansagrowingconcernregardingprogestagens